Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
186.80    0.00 (0.00%)
Bid:
0.00
Ask:
230.00
Spread: 43.60 (23.391%)
Market Cap: £1.88b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Trading Update

8 Sep 2021 09:36

RNS Number : 1062L
B&M European Value Retail S.A.
08 September 2021
 

 

 

 

8 September 2021

B&M European Value Retail S.A.

 

H1 FY22 Trading Update

 

 

B&M European Value Retail S.A. ("the Group"), the UK's leading variety goods value retailer, today provides a trading update relating to its performance to date for the half year ending 25 September 2021 ("H1 FY22").

 

Whilst Group revenues year to date have been broadly in line with market expectations, gross margins have been stronger than originally anticipated in the B&M UK fascia business.

 

Performance of General Merchandise and Seasonal categories has been particularly encouraging. Sell-through rates in those categories have been high and accordingly end of season markdowns have been limited.

 

As a consequence, the Group now expects adjusted EBITDA1 (on a pre-IFRS16 basis) for H1 FY22 (covering the 26 week period to 25 September 2021) to be in the range of £275m to £285m. The analysts' consensus estimate2 for H1 FY22 adjusted EBITDA1 is currently approximately £235m.

 

Although the Group is well positioned for the upcoming Golden Quarter, trading patterns and strength of customer demand remain highly uncertain for the balance of FY22.

 

The Group will provide further detail in its FY22 Interim Results on 11 November 2021.

 

This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation.

 

 

1. The Directors consider adjusted EBITDA figures to be more reflective of the underlying business performance of the Group and believe that this measure provides additional useful information for investors on the Group's performance. Adjusting items are the effects of derivatives, one off refinancing fees, foreign exchange on the translation of intercompany balances and the effects of revaluing or unwinding balances related to the acquisition of subsidiaries.

2. The consensus estimate for adjusted EBITDA in H1 FY22 is based upon the average of 10 analysts who have provided estimates for that period.

 

 

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400 ext 5763

Simon Arora, Chief Executive

Alex Russo, Chief Financial Officer

Jonny Armstrong, Head of Investor Relations

Investor.relations@bandmretail.com

 

Media

For media please contact +44 (0) 207 379 5151

Sam Cartwright, Maitland

bmstores-maitland@maitland.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGIGDCXXGDGBI
Date   Source Headline
20th Aug 20181:30 pmRNSDirector/PDMR Shareholding
2nd Aug 20187:00 amRNSOrdinary General Meeting
31st Jul 201811:09 amRNSResults of AGM & EGM
31st Jul 20187:00 amRNSBoard Appointments & Retirement
16th Jul 20189:09 amRNSBlock listing Interim Review
12th Jul 20187:00 amRNSTrading Update
21st Jun 20188:30 amRNSAnnual Financial Report
19th Jun 20187:00 amRNSHolding(s) in Company
30th May 20187:00 amRNSPreliminary Results
15th May 20189:43 amRNSHolding(s) in Company
31st Jan 20187:00 amRNSTotal Voting Rights
19th Jan 20187:00 amRNSNon-Executive Director Retirement
15th Jan 20189:00 amRNSBlock listing Interim Review
15th Jan 20187:00 amRNSResult of Equity Issue
12th Jan 20187:00 amRNSTrading Statement
30th Nov 20178:00 amRNSTotal Voting Rights
22nd Nov 20179:00 amRNSDirector/PDMR Shareholding
14th Nov 20177:05 amRNSChairman Appointment
14th Nov 20177:00 amRNSHalf-year Report
27th Oct 20178:43 amRNSDirector Declaration
31st Aug 20178:00 amRNSTotal Voting Rights
7th Aug 20173:51 pmRNSDirector/PDMR Shareholding
2nd Aug 20178:16 amRNSAcquisition of Heron Food Group Limited
31st Jul 20171:02 pmRNSResult of AGM
13th Jul 20179:36 amRNSBlock Listing Application
12th Jul 20177:00 amRNSTrading Statement
22nd Jun 20179:00 amRNSAnnual Financial Report
9th Jun 20179:34 amRNSHolding(s) in Company
7th Jun 20172:10 pmRNSDirector/PDMR Shareholding
7th Jun 20172:00 pmRNSHolding(s) in Company
2nd Jun 20177:00 amRNSResult of Placing in B&M European Value Retail SA
1st Jun 20176:19 pmRNSPlacing of shares in B&M European Value Retail SA
25th May 20177:00 amRNSPreliminary Results
18th Apr 20175:39 pmRNSHolding(s) in Company
27th Mar 20175:43 pmRNSHolding(s) in Company
31st Jan 20179:13 amRNSB&M Post Stabilisation Notice
26th Jan 20174:26 pmRNSB&M Pre-Stabilisation Notice
26th Jan 20172:59 pmRNSPricing of Senior Secured Notes Offering
23rd Jan 20177:56 amRNSLaunch of Senior Secured Notes Offering
4th Jan 20177:00 amRNSTrading Statement
22nd Dec 201610:37 amRNSHolding(s) in Company
16th Dec 20169:15 amRNSHolding(s) in Company
15th Nov 20167:00 amRNSHalf-year Report
19th Oct 20162:13 pmRNSHolding(s) in Company
19th Oct 201610:43 amRNSHolding(s) in Company
11th Oct 20162:55 pmRNSHolding(s) in Company
10th Oct 20169:42 amRNSHolding(s) in Company
18th Aug 201612:37 pmRNSDirector/PDMR Shareholding
16th Aug 20164:04 pmRNSHolding(s) in Company
2nd Aug 20167:00 amRNSResults of AGM & EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.